文献速递生殖医学妇科

从单组学到多组学识别胚胎成功着床的生物标志物

Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes.
PubMed 文献 · Hum Reprod Update · 2020-01-01

本文综述了截至2019年9月关于胚胎和子宫内膜分子决定因素的组学研究,指出尽管组学提供了大量生物标志物信息,但不同研究间存在差异,且胚胎与子宫内膜分子特征常未联合分析,导致难以得出确切结论。未来需整合微创或非创组学工具与统一数据解读,以推动个性化单胚胎移植。

要点

  • 组学研究鉴定出潜在着床生物标志物,但罕有临床实施。
  • 胚胎与子宫内膜分子特征常未联合分析,阻碍确切结论。
  • 微创组学与整合数据解读有望推动个性化单胚胎移植。

核心结论

  • 组学提供了大量生物标志物信息,但尚不足以将数据与着床结局关联。
  • 未来需微创组学工具与整合解读统一收集的数据以助临床实施。

研究设计与样本

  • 综述检索Medline至2019年9月,无语言限制,关键词涵盖转录组、蛋白质组、分泌组、代谢组和表达谱等组学及着床相关术语。

主要发现

  • 即使采用相同组学分析,胚胎活力或子宫内膜容受性研究提出的生物标志物间存在差异。
  • 组学增进了对着床过程的理解,识别出潜在但罕有实施的着床成功生物标志物。

临床怎么用

  • 胚胎和子宫内膜组学检测正被提议或已用作诊断工具,用于在最佳子宫内膜环境下个性化单胚胎移植,避免多胎妊娠风险并确保更好妊娠率。

局限性

  • 胚胎与子宫内膜分子特征常未联合研究,且不同组学研究结果存在差异,阻碍确切结论。
  • 仍无足够证据将全部组学数据与着床结局关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Successful embryo implantation is a complex process that requires the coordination of a series of events, involving both the embryo and the maternal endometrium. Key to this process is the intricate cascade of molecular mechanisms regulated by endocrine, paracrine and autocrine modulators of embryonic and maternal origin. Despite significant progress in ART, implantation failure still affects numerous infertile couples worldwide and fewer than 10% of embryos successfully implant. Improved selection of both the viable embryos and the optimal endometrial phenotype for transfer remains crucial to enhancing implantation chances. However, both classical morphological embryo selection and new strategies incorporated into clinical practice, such as embryonic genetic analysis, morphokinetics or ultrasound endometrial dating, remain insufficient to predict successful implantation. Additionally, no techniques are widely applied to analyse molecular signals involved in the embryo-uterine interaction. More reliable biological markers to predict embryo and uterine reproductive competence are needed to improve pregnancy outcomes. Recent years have seen a trend towards 'omics' methods, which enable the assessment of complete endometrial and embryonic molecular profiles during implantation. Omics have advanced our knowledge of the implantation process, identifying potential but rarely implemented biomarkers of successful implantation. OBJECTIVE AND RATIONALE: Differences between the findings of published omics studies, and perhaps because embryonic and endometrial molecular signatures were often not investigated jointly, have prevented firm conclusions being reached. A timely review summarizing omics studies on the molecular determinants of human implantation in both the embryo and the endometrium will help facilitate integrative and reliable omics approaches to enhance ART outcomes. SEARCH METHODS: In order to provide a comprehensive review of the literature published up to September 2019, Medline databases were searched using keywords pertaining to omics, including 'transcriptome', 'proteome', 'secretome', 'metabolome' and 'expression profiles', combined with terms related to implantation, such as 'endometrial receptivity', 'embryo viability' and 'embryo implantation'. No language restrictions were imposed. References from articles were also used for additional literature. OUTCOMES: Here we provide a complete summary of the major achievements in human implantation research supplied by omics approaches, highlighting their potential to improve reproductive outcomes while fully elucidating the implantation mechanism. The review highlights the existence of discrepancies among the postulated biomarkers from studies on embryo viability or endometrial receptivity, even using the same omic analysis. WIDER IMPLICATIONS: Despite the huge amount of biomarker information provided by omics, we still do not have enough evidence to link data from all omics with an implantation outcome. However, in the foreseeable future, application of minimally or non-invasive omics tools, together with a more integrative interpretation of uniformly collected data, will help to overcome the difficulties for clinical implementation of omics tools. Omics assays of the embryo and endometrium are being proposed or already being used as diagnostic tools for personalised single-embryo transfer in the most favourable endometrial environment, avoiding the risk of multiple pregnancies and ensuring better pregnancy rates.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Hernández-Vargas P, Muñoz M, Domínguez F, et al. Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes. Hum Reprod Update. 2020. PMID: 32096829. doi:10.1093/humupd/dmz042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。